Nexgen Biofuels (NXGN) Tops Q2 EPS by 5c

Go back to Nexgen Biofuels (NXGN) Tops Q2 EPS by 5c

Morgan Stanley Upgrades NextGen Healthcare Inc (NXGN) to Equalweight

November 1, 2018 1:54 PM EDT

Morgan Stanley analyst Ricky Goldwasser upgraded NextGen Healthcare Inc (NASDAQ: NXGN) from Underweight to Equalweight with a price target of $16.00.

For an analyst ratings summary and ratings history on NextGen Healthcare Inc... More

NextGen Healthcare Inc (NXGN) PT Lowered to $15 at RBC Capital

October 31, 2018 7:52 AM EDT

RBC Capital analyst George Hill lowered the price target on NextGen Healthcare Inc (NASDAQ: NXGN) to $15.00 (from $17.00) while maintaining a Underperform rating.

... More